ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645317; 2) Community: the network communities that were significantly associated with the response to NSC 645317; 3) Molecule: the relationships between components within communities and NSC 645317; 4) MDR: the compounds that were significantly associated with the NSC 645317.

NSC Compound Enrichment Correlation
NSC 740253 Null 0.0262961536448272 0.32728356
NSC 750721 10-(3,4-dimethoxyphenyl)-6-(2-hydroxyethyl)-2,3,7,10-tetrahydro-[1,4]dioxino[2,3-g]furo[3,4-b]quinolin-9(6H)-one 0.0262961536448272 0.38924905
NSC 753585 N1-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]-2-2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxyacetamide 0.0262961536448272 0.44222334
NSC 756468 SB-725317 0.0262961536448272 0.32594336
NSC 78365 Guanidine, 1-(p-butoxyphenyl)-3-(p-chlorophenyl)- 0.0262961536448272 0.076490055
NSC 86354 (p-Nitrophenyl)phenyliodonium bromide 0.0262961536448272 0.37562381
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0267520285931239 0.57539278
NSC 176323 Camptothecin Derivative 0.0267520285931239 0.24563619
NSC 178248 Chlorozotocin 0.0267520285931239 0.097785855
NSC 237671 Actinomycin X4357g-methoxime 0.0267520285931239 0.48749209
Total:127  Current:82    [First] [Prev] [Next] [Last]